Marks LD - Search Results

1

Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.

Kris MG, Kinahan JJ, Gralla RJ, Fanucchi MP, Wertheim MS, O'Connell JP, Marks LD, Williams L, Farag F, Young CW, et al. Kris MG, et al. Among authors: marks ld. Cancer Res. 1988 Oct 1;48(19):5573-9. Cancer Res. 1988. PMID: 3416310 Clinical Trial.

2

Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancer.

Rigas JR, Kris MG, Gralla RJ, Heelan RT, Marks LD. Rigas JR, et al. Among authors: marks ld. Invest New Drugs. 1991 May;9(2):187-90. doi: 10.1007/BF00175087. Invest New Drugs. 1991. PMID: 1651908 Clinical Trial.

3

Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.

Berger MZ, Kris MG, Gralla RJ, Marks LD, Potanovich LM, Dimaggio JJ, Heelan RT. Berger MZ, et al. Among authors: marks ld. Am J Clin Oncol. 1991 Apr;14(2):124-6. doi: 10.1097/00000421-199104000-00006. Am J Clin Oncol. 1991. PMID: 1851387

4

Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer.

Kris MG, D'Acquisto RW, Gralla RJ, Burke MT, Marks LD, Fanucchi MP, Heelan RT. Kris MG, et al. Among authors: marks ld. Am J Clin Oncol. 1989 Feb;12(1):24-6. doi: 10.1097/00000421-198902000-00006. Am J Clin Oncol. 1989. PMID: 2536213

5

Phase II study of 10-ethyl-10-deaza-aminopterin in patients with stage III and IV non-small-cell lung cancer.

Shum KY, Kris MG, Gralla RJ, Burke MT, Marks LD, Heelan RT. Shum KY, et al. Among authors: marks ld. J Clin Oncol. 1988 Mar;6(3):446-50. doi: 10.1200/JCO.1988.6.3.446. J Clin Oncol. 1988. PMID: 2832548

6

Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.

Kris MG, Gralla RJ, Burke MT, Berkowitz LD, Marks LD, Kelsen DP, Heelan RT. Kris MG, et al. Among authors: marks ld. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):763-4. Cancer Treat Rep. 1987. PMID: 3038318 No abstract available.

7

Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.

Kris MG, Gralla RJ, Burke MT, Fiore JJ, Kelsen DP, Marks LD, Heelan RT. Kris MG, et al. Among authors: marks ld. Cancer Treat Rep. 1987 Jul-Aug;71(7-8):783-4. Cancer Treat Rep. 1987. PMID: 3038319 No abstract available.

8

Oral piritrexim--a phase II study in patients with advanced soft tissue sarcoma.

Schiesel JD, Carabasi M, Magill G, Casper E, Cheng E, Marks L, Feyzi J, Clendeninn NJ, Smalley RV. Schiesel JD, et al. Invest New Drugs. 1992 Jul;10(2):97-8. doi: 10.1007/BF00873124. Invest New Drugs. 1992. PMID: 1500271 Clinical Trial. No abstract available.

9

What Puts the "Tribo" in Triboelectricity?

Olson KP, Marks LD. Olson KP, et al. Among authors: marks ld. Nano Lett. 2024 Oct 2;24(39):12299-12306. doi: 10.1021/acs.nanolett.4c03656. Epub 2024 Sep 17. Nano Lett. 2024. PMID: 39288099

10

Flexoelectricity, Triboelectricity, and Free Interfacial Charges.

Marks LD, Olson KP. Marks LD, et al. Small. 2024 Aug 25:e2310546. doi: 10.1002/smll.202310546. Online ahead of print. Small. 2024. PMID: 39183520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters